Company intelligence / Profile preview
JSIAMA Biopharmaceuticals
Suzhou, Jiangsu, Chinaiamabio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
JSIAMA Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer. The company leverages its proprietary antibody engineering platform to design next-generation biologics, including bispecific antibodies and antibody-drug conjugates (ADCs). Its pipeline features several candidates targeting well-validated immune checkpoints and tumor-associated antigens, with lead programs currently in Phase 2 clinical trials. JSIAMA aims to address significant unmet medical needs in oncology by providing more effective and safer treatment options for patients with various solid tumors.
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyAntibody-drug conjugate
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on JSIAMA Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JSIAMA Biopharmaceuticals.